Source: MyPhenome genetic obesity test
What You Should Know:
– Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.
– The research will evaluate…
Continue Reading
What You Should Know:
– Phenomix Sciences, a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading…
Continue Reading
What You Should Know: – Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care. – The survey of 475 patients explored attitudes…
Continue Reading
Virtual primary care platform Hello Alpha has teamed up with Phenomix Sciences, a precision medicine biotechnology company, the companies announced Tuesday. The partnership will give Hello Alpha’s patients access to Phenomix Sciences’ genetic obesity…
Continue Reading
What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc….
Continue Reading
The first article in this series laid out what we know about body weight and obesity today. The rest of the Lean Digital series will look at some contributions that digital technologies are making…
Continue Reading
What You Should Know:
– Phenomix Sciences, a leader in precision medicine for obesity, launches a new MyPhenome test that identifies all three key obesity phenotypes in a single test.
– The new test identifies all…
Continue Reading
The Platform Offers Comprehensive, Tailored Threat Intelligence and Risk Assessment, Empowering Hospitals and Health Systems to Protect Patient Data with Precision
Health2047, a Silicon Valley-based venture studio founded by the American Medical Association (AMA), today…
Health2047’s Newest Portfolio Company Unveils First-of-its-Kind Medical Imaging AI Platform Powered by Amazon Web Services; Early Partners Include RadNet and Rad AI
Today, HOPPR announces the launch of Grace, a multi-modal foundation model for medical…
